Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics Previous close 1,130.00
Open 1,130.00
Day range —
52-week range 789.00 1,153.00
Off day high 0.00%
Off 52-week high −1.99%
Volume 0.00
Avg. volume (3M) 306
Market cap 2.31T
EPS (TTM) 81.70
Forward P/E —
P/E ratio (TTM) 13.83
Dividend yield 4.11% (46.49)
Beta (5Y) —
Shares outstanding 2.04B
Short interest —
Earnings date Oct 29, 2026
Analyst target —
Profit margin —
No recent coverage in the 4Search index.
From articles in the 4Search news index.
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban (Eliquis) for people with atrial fibrillation ; nivolumab (Opdivo), used to treat certain types of cancer ; lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes ; abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid arthritis ; pomalidomid…
From Wikipedia , CC BY-SA 4.0
Earnings
Next report: Thu, Oct 29, 2026
Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).
Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).
Not eligible for Growth tech (U.S. technology stocks only).
Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).
A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.
Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use .